Skip to main content
SpringerLink
Log in

Psoriasis

  • Chapter
Psoriasis and Psoriatic Arthritis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman AB (1997) Psoriasis. In: Ackerman AB (ed) Histologic diagnosis of inflammatory skin diseases. An algorithmic method based on pattern analysis. Lippincott Williams and Wilkins, Baltimore, pp 663–673

    Google Scholar 

  2. Ackermann L, Harvima IT, Pelkonen J, RitamakiSalo V, Naukkarinen A, Harvima RJ, Horsmanheimo M (1999) Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 140: 624–633

    Article  PubMed  CAS  Google Scholar 

  3. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752–759

    Article  PubMed  CAS  Google Scholar 

  4. Balendran N, Clough RL, Arguello JR, Barber R, Veal C, Jones AB, Rosbotham JL, Little AM, Madrigal A, Barker JN, Powis SH, Trembath RC (1999) Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol 113: 322–328

    Article  PubMed  CAS  Google Scholar 

  5. Barker JN (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26: 321–325

    PubMed  CAS  Google Scholar 

  6. Bianchi L, Farrace MG, Nini G, Piacentini M (1994) Abnormal Bcl-2 and “tissue” transglutaminase expressio in psoriatic skin. J Invest Dermatol 103: 829–833

    Article  PubMed  CAS  Google Scholar 

  7. Biondi Oriente C, Scarpa R, Pucino A, Oriente P (1989) Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) 146: 69–71

    CAS  Google Scholar 

  8. Boehncke WH, Sterry W, Hainzl A, Scheffold W, Kaufmann R (1994) Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice. Arch Dermatol Res 286: 325–330

    PubMed  CAS  Google Scholar 

  9. Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R (1996) Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 132: 176–180

    Article  PubMed  CAS  Google Scholar 

  10. Bos JD (1988) The pathomechanisms of psoriasis; the skin immune system and cyclosporin. Br J Dermatol 118: 141–155

    PubMed  CAS  Google Scholar 

  11. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, Catier J, Fernandez-Vina MA, Menter A (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 10: 1793–1805

    Article  PubMed  CAS  Google Scholar 

  12. Boyman O, Hefti HP, Suter M, Nickoloff BJ, Nestle FO (2002) TBA-alpha-dependent induction of psoriasis in the absence of lymphocyte recruitment. Br J Dermatol 147: 1047–1078

    Google Scholar 

  13. Braun-Falco O (1991) Psoriasis vulgaris. In: Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK (eds) Dermatology. Springer, Berlin Heidelberg New York, pp 417–437

    Google Scholar 

  14. Burden AD (2000) Identifying a gene for psoriasis on chromosome 6 (Psors1). Br J Dermatol 143: 238–241

    Article  PubMed  CAS  Google Scholar 

  15. Cai JP, Harris K, Falanga V, Taylor JR, Chin YH (1996) UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques. Br J Dermatol 134: 7–16

    Article  PubMed  CAS  Google Scholar 

  16. Champion RH (1986) Psoriasis. Br Med J (Clin Res Ed) 292: 1693–1696

    Article  CAS  Google Scholar 

  17. Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ (2000) The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br J Dermatol 143: 324–329

    Article  PubMed  CAS  Google Scholar 

  18. Chin YH, Falanga V, Taylor JR, Cai JP, Bax J (1990) Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J Invest Dermatol 94: 413–417

    Article  PubMed  CAS  Google Scholar 

  19. Christophers E, Henseler T (1985) Characterization of disease patterns in nonpustular psoriasis. Semin Dermatol 4: 271–275

    Google Scholar 

  20. Christophers E, Mrowietz U (1999) Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K (eds) Dermatology in general medicine, 5th edn. McGraw Hill, New York, pp 495–521

    Google Scholar 

  21. Creamer JD, Barker JN (1995) Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol 20: 6–9

    PubMed  CAS  Google Scholar 

  22. Curry JL, Qin J-Z, Bonish B, Carrick R, Bacon P, Panella J, Robinson J, Nickoloff BJ (2003) Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med 127: 178–186

    PubMed  CAS  Google Scholar 

  23. Daoud P, Mirc M, Tarazourte MF, Pollak M, Rousset A, Castaing H (2000) Neonatal hyperparathyroidism secondary to unknown maternal hypoparathyroidism. Arch Pediatr 7: 45–48

    Article  PubMed  CAS  Google Scholar 

  24. Dover R, Wright NA (1993) Biology and function of epidermis and appendages. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine. McGraw-Hill, New York, p 159

    Google Scholar 

  25. Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin Exp Immunol 135: 64–73

    Article  PubMed  CAS  Google Scholar 

  26. Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29: 428–434

    Article  PubMed  CAS  Google Scholar 

  27. Ekholm E, Egelrud T (1999) Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 291: 195–200

    Article  PubMed  CAS  Google Scholar 

  28. Elder JT, Nair RP, Voorhees JJ (1994) Epidemiology and the genetics of psoriasis. J Invest Dermatol 102: 24S–27S

    Article  PubMed  CAS  Google Scholar 

  29. Favre M, Majewski S, Noszczyk B, Maienfisch F, Pura A, Orth G, Jablonska S (2000) Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114: 403–407

    Article  PubMed  CAS  Google Scholar 

  30. Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB (1996) Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 107: 778–782

    Article  PubMed  CAS  Google Scholar 

  31. Gillum PS, Golitz LE (1998) Psoriasiform dermatitis. In: Barnhill RL (ed) Textbook of dermatopathology. McGraw Hill, New York, pp 55–68

    Google Scholar 

  32. Gonzalez S, Martinez-Borra J, Del Rio JS, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, Lopez-Larrea C (2000) The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol 115: 824–828

    PubMed  CAS  Google Scholar 

  33. Goodfield M, Macdonald Hull SM, Holland D, Roberts G, Wood E, Reid S (1994) Investigations of the ‘active’ edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin. Br J Dermatol 131: 808–813

    PubMed  CAS  Google Scholar 

  34. Gordon M, Johnson WC (1967) Histopathology and histochemistry of psoriasis: I. The active lesion and clinically normal skin. Arch Dermatol 95: 402–407

    Article  PubMed  CAS  Google Scholar 

  35. Griffiths CE (1994) Cutaneous leukocyte trafficking and psoriasis. Arch Dermatol 130: 494–499

    PubMed  CAS  Google Scholar 

  36. Haase I, Pasparakis M (2002) A new mouse model for psoriasis: evidence for a TNF-mediated, T cell-independent pathogenesis. Br J Dermatol 47: 1047–1078

    Google Scholar 

  37. Herbst RA, Hoch O, Kapp A, Weiss J (2000) Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol 42: 885–887

    PubMed  CAS  Google Scholar 

  38. Irimajiri J, Yamamoto T, Rimura K, Yokozeki H, Nishioka K (1998) Verruca vulgaris developing during cyclosporin therapy for psoriasis vulgaris. J Dermatol 25: 688–690

    PubMed  CAS  Google Scholar 

  39. Kere J (2002) PSORS1: towards gene identification. Br J Dermatol 147: 1047–1078

    Google Scholar 

  40. Kono T, Tanii T, Furukawa M, Mizuno N, Taniguchi S, Ishii M, Hamada T (1990) Effects of human recombinant tumor necrosis factor-alpha (TNF-alpha) on the proliferative potential of human keratinocytes cultured in serum-free medium. J Dermatol 17: 409–413

    PubMed  CAS  Google Scholar 

  41. Krueger GG, Eyre RW (1984) Trigger factors in psoriasis. Dermatol Clin 2: 373–381

    Google Scholar 

  42. Kulke R, Bornscheuer E, Schluter C, Bartels J, Rowert J, Sticherling M, Christophers E (1998) The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 110: 90–94

    Article  PubMed  CAS  Google Scholar 

  43. Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN (1995) Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 133: 501–511

    PubMed  CAS  Google Scholar 

  44. Leung D, Walsh P, Giorno R, Norris D (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100: 225–228

    Article  PubMed  CAS  Google Scholar 

  45. Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ (1995) Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyteassociated antigen via stimulation of interleukin 12 production. J Exp Med 181: 747–753

    PubMed  CAS  Google Scholar 

  46. Linhart C, Wolter M, Kaufmann R (2003) Psoriasiforme entzündliche Dermatosen. In: Kerl H, Garbe C, Cerroni L, Wolff HH (eds) Histopathologie der Haut, 1st edn. Springer, Berlin Heidelberg New York, pp 145–150

    Google Scholar 

  47. Lowe PM, Lee ML, Jackson CJ, To SS, Cooper AJ, Schrieber L (1995) The endothelium in psoriasis. Br J Dermatol 132: 497–505

    PubMed  CAS  Google Scholar 

  48. Ludolph-Hauser D, Schubert C, Wiedow O (1999) Structural changes of human epidermis induced by human leukocyte-derived proteases. Exp Dermatol 8: 46–52

    PubMed  CAS  Google Scholar 

  49. Mahe E, Bodemer C, Descamps V, Mahe I, Crickx B, De Prost Y, Favre M (2003) High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol 149: 819–825

    PubMed  CAS  Google Scholar 

  50. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R, Bunker CB (1998) HLA-Cw*0602 and HIV-associated psoriasis. Br J Dermatol 139: 527–533

    Article  PubMed  CAS  Google Scholar 

  51. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, Bunker CB (2000) HLA-C and guttate psoriasis. Br J Dermatol 143: 1177–1182

    Article  PubMed  CAS  Google Scholar 

  52. Molhuizen HO, Schalkwijk J (1995) Structural, biochemical, and cell biological aspects of the serine proteinase inhibitor SKALP/elafin/ESI. Biol Chem Hoppe Seyler 376: 1–7

    PubMed  CAS  Google Scholar 

  53. Mommers JM, van Rossum MM, van Erp PE, van de Kerkhof PC (2000) Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 201: 15–20

    Article  PubMed  CAS  Google Scholar 

  54. Moynihan GD, Ruppe JP Jr (1985) Impetigo herpetiformis and hypoparathyroidism. Arch Dermatol 121: 1330–1331

    Article  PubMed  CAS  Google Scholar 

  55. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees JJ, Elder JT (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66: 1833–1844

    Article  PubMed  CAS  Google Scholar 

  56. Naldi L, Peli L, Parazzini F, Carrel CF, Psoriasis Study Group of the Italian Group for Epidemiological Research in Dermatology (2001) Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: Results of a case-control study. J Am Acad Dermatol 44: 433–438

    Article  PubMed  CAS  Google Scholar 

  57. Nanney LB, Yates RA, King LE Jr (1992) Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topicals EGF. J Invest Dermatol 98: 296–301

    Article  PubMed  CAS  Google Scholar 

  58. Navarro JM, Casatorres J, Jorcano JL (1995) Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. J Biol Chem 270: 21362–21367

    PubMed  CAS  Google Scholar 

  59. Nickoloff BJ (1999) The immunologic and genetic basis of psoriasis. Arch Dermatol 135: 1104–1110

    PubMed  CAS  Google Scholar 

  60. Nickoloff BJ, Wrone-Smith T (1998) Superantigens, autoantigens, and pathogenic T cells in psoriasis. J Invest Dermatol 110: 459–460

    PubMed  CAS  Google Scholar 

  61. Penas PF, Gomez M, Buezo GF, Rios L, Yanez-Mo M, Cabanas C, Sanchez-Madrid F, Garcia-Diez A (1998) Differential expression of activation epitopes of beta1 integrin in psoriasis and normal skin. J Invest Dermatol 111: 19–24

    Article  PubMed  CAS  Google Scholar 

  62. Petzelbauer P, Pober JS, Keh A, Braverman IM (1994) Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 103: 300–305

    Article  PubMed  CAS  Google Scholar 

  63. Piepkorn M (1996) Overexpression of amphiregulin, a major autocrine growth factor for cultured human keratinocytes, in hyperproliferative skin disease. Am J Dermatopathol 18: 165–171

    Article  PubMed  CAS  Google Scholar 

  64. Plant D, Lear J, Marsland A, Worthington J, Griffiths CEM (2002) NOD2 single nucleotide polymorphisms do not confer susceptibility to chronic plaque psoriasis. Br J Dermatol 147: 1047–1078

    Google Scholar 

  65. Prinz JC (1999) Which T cells cause psoriasis? Clin Exp Dermatol 24: 291–295

    Article  PubMed  CAS  Google Scholar 

  66. Prinz JC (2001) Psoriasis vulgaris, a sterile antibacterial skin reaction, mediated by cross-reactive Tcells? An immunological view on the pathophysiology of psoriasis. Clin Exp Dermatol 26: 326–332

    Article  PubMed  CAS  Google Scholar 

  67. Rajendran SS, Premalatha S, Yesudian P, Zahra A (1984) Psoriasis verruciformis. Int J Dermatol 23: 552–553

    PubMed  CAS  Google Scholar 

  68. Russell TJ, Schultes LM, Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287: 738–740

    Article  PubMed  CAS  Google Scholar 

  69. Sayama K, Midorikawa K, Hanakawa Y, Sugai M, Hashimoto K (1998) Superantigens production by Staphylococcus aureus in psoriasis. Dermatology 196: 194–198

    Article  PubMed  CAS  Google Scholar 

  70. Schalkwijk J, Chang A, Janssen P, de Jongh GJ, Mier PD (1990) Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol 122: 631–641

    PubMed  CAS  Google Scholar 

  71. Schroder JM, Gregory H, Young J, Christophers E (1992) Neutrophil-activating proteins in psoriasis. J Invest Dermatol 98: 241–247

    Article  PubMed  CAS  Google Scholar 

  72. Skov L, Baadsgaard O (2000) Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 25: 57–61

    Article  PubMed  CAS  Google Scholar 

  73. Smith CH, Barker JNWN (1995) Cell trafficking and role of adhesion molecules in psoriasis. In: van de Kerkhof PCM, Bos JD (eds) Pathogenetic aspects of psoriasis. Elsevier, New York, pp 151–160

    Google Scholar 

  74. Snowden JA, Heaton DC (1997) Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 137: 130–132

    Article  PubMed  CAS  Google Scholar 

  75. Steffen C (2002) William John Munro and Munro’s abscess, and Franz Kogoj and Kogoj’s spongiform pustule. Am J Dermatopathol 24: 364–368

    PubMed  Google Scholar 

  76. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J, Enerback C, Enlund F, Yhr M (1995) Age at onset and different types of psoriasis. Br J Dermatol 133: 768–773

    PubMed  CAS  Google Scholar 

  77. Sweet WL, Smoller BR (1997) Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis. J Cutan Pathol 24: 356–363

    PubMed  CAS  Google Scholar 

  78. Szepietowski J, Wasik F, Bielicka E, Nockowski P, Noworolska A (1999) Soluble E-selectin serum levels correlate with disease activity in psoriasis patients. Clin Exp Dermatol 24: 33–36

    Article  PubMed  CAS  Google Scholar 

  79. Takematsu H, Tagami H (1993) Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 129: 74–80

    Article  PubMed  CAS  Google Scholar 

  80. Tanaka N, Fujioka A, Tajima S, Ishibashi A, Hirose S (2000) Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1beta and tumor necrosis factor-alpha stimulate its secretion in vitro. Br J Dermatol 143: 728–732

    PubMed  CAS  Google Scholar 

  81. Telfer NR, Chalmers RJ, Whale K, Colman G (1992) The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 128: 39–42

    Article  PubMed  CAS  Google Scholar 

  82. Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M (1980) Psoriasis and HLA-Cw6. Br J Dermatol 102: 179–184

    PubMed  CAS  Google Scholar 

  83. Travis L, Weinberg JM (2002) Medical background: Psoriasis. Drugs Today (Barc) 38: 847–865

    Article  PubMed  Google Scholar 

  84. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L (1995) Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16: 145–149

    Article  PubMed  CAS  Google Scholar 

  85. Van de Kerkhof PCM (1986) Clinical features. In: Mier PD, van der Kerkhof PCM (eds) Textbook of psoriasis. Churchill Livingstone, Edinburgh, pp 13–39

    Google Scholar 

  86. Van de Kerkhof PCM (2003) Psoriasis. In: Bolognia JL, Jorizzo JL, Rapini RP, Horn TD, Mancini AJ, Mascaro JM, Salasche SJ, Saurat JH, Stingl G (eds) Dermatology. Mosby, St. Louis, pp 125–149

    Google Scholar 

  87. Van de Kerkhof PCM, Gerritsen MJP, de Jong EMGJ (1996) Transition from symptomless to lesional psoriatic skin. Clin Exp Dermatol 21: 325–329

    PubMed  Google Scholar 

  88. Van der Fits L, Van der Wel LI, Boogaard MW, Laman JD, Versuchen MCM, Prens EP (2002) Type I and Type II interferon signalling are both activated in lesional psoriatic skin. Br J Dermatol 147: 1047–1078

    Google Scholar 

  89. Wakita H, Takigawa M (1994) E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 130: 457–463

    Article  PubMed  CAS  Google Scholar 

  90. Watts P, Stables GS, Akhurst RJ, MacKie RM (1994) Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. Br J Dermatol 131: 64–71

    PubMed  CAS  Google Scholar 

  91. Weedon D (2002) The psoriasiform reaction pattern. In: Weedon D (ed) Skin pathology. Churchill Livingstone, London, pp 76–83

    Google Scholar 

  92. Weinstein GD, Van Scott EJ (1965) Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J Invest Dermatol 45: 257–262

    Article  PubMed  CAS  Google Scholar 

  93. Wiedow O, Schroder J-M, Gregory H, Young JA, Christophers E (1990) Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265: 14791–14795

    PubMed  CAS  Google Scholar 

  94. Wiedow O, Wiese F, Streit V, Kalm C, Christophers E (1992) Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol 99: 306–309

    Article  PubMed  CAS  Google Scholar 

  95. Wiedow O, Wiese F, Christophers E (1995) Lesional activity in psoriasis. Diagnostic and prognostic significance. Arch Dermatol Res 287: 632–635

    Article  PubMed  CAS  Google Scholar 

  96. Young HS, Summers AM, Bhushan M, Brenchley PEC, Griffiths CE (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122: 209–215

    Article  PubMed  CAS  Google Scholar 

  97. Zhou S, Matsuyoshi N, Takeuchi T, Ohtsuki Y, Miyachi Y (2003) Reciprocal altered expression of T-cadherin and P-cadherin in psoriasis vulgaris. Br J Dermatol 149: 268–273

    Article  PubMed  CAS  Google Scholar 

  98. Zimmerman GM (1999) Alcohol and psoriasis. Arch Dermatol 135: 1541–1542

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

    Bettina M. Prinz Vavricka MD

  2. Department of Dermatology, Northwestern University, Chicago, IL, USA

    Joan Guitart MD

Authors
  1. Bettina M. Prinz Vavricka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joan Guitart MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Loyola University, Stritch School of Medicine, 2160 S. First Ave., Building 112, Room 342, Maywood, IL, 60153, USA

    Kenneth B. Gordon MD

  2. Division of Rheumatology, Northwestern University, Feinberg School of Medicine, 675 N. St. Clair St., Chicago, IL, 60611, USA

    Eric M. Ruderman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Prinz Vavricka, B.M., Guitart, J. (2005). Psoriasis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-27190-2_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21280-5

  • Online ISBN: 978-3-540-27190-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation